Its target, CD30, is a type I transmembrane receptor protein whose expression is characteristic in all types of anaplastic large cell lymphoma but whose expression in benign tissues is limited to activated and virally infected lymphocytes and certain cells of the thymic medulla [54]. Here, TNFRSF8 is linked to anaplastic large cell lymphoma.